What vaccine should a child receive after getting Td (tetanus and diphtheria) vaccine at 10 years instead of TdaP (tetanus, diphtheria, and pertussis) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaccination Recommendation After Td at Age 10

A child who received Td vaccine at age 10 years instead of Tdap should receive a single dose of Tdap as soon as possible, with no minimum interval required between the Td and Tdap doses.

Rationale for Immediate Tdap Administration

The primary concern in this situation is ensuring protection against pertussis, which was missing from the Td vaccine the child received. According to the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP), there is no minimum interval required between receipt of a tetanus toxoid-containing vaccine (like Td) and subsequent Tdap administration when Tdap is indicated 1.

This recommendation represents a change from earlier guidance that suggested waiting 5 years between tetanus-containing vaccines. Accumulating data have demonstrated no increased risk of severe local reactions or serious adverse events when Tdap is administered at short intervals after previous tetanus or diphtheria toxoid-containing vaccines 1, 2.

Implementation Considerations

When administering Tdap to this child, consider the following:

  • Vaccine formulation: For a 10-year-old child, Boostrix (one brand of Tdap) is licensed for use beginning at age 10, while Adacel is only licensed for children beginning at age 11 1. Therefore, Boostrix would be the appropriate Tdap formulation for a 10-year-old.

  • Documentation: Clearly document that this Tdap dose is being given to provide protection against pertussis that was missing from the previous Td vaccination.

  • Future vaccinations: After receiving Tdap, the child should follow the standard adolescent vaccination schedule for subsequent vaccines, including:

    • Meningococcal conjugate vaccine (MCV4) at age 11-12 years
    • HPV vaccine series beginning at age 11-12 years 3

Special Considerations

  • If the child has any contraindications to pertussis vaccination (such as history of encephalopathy within 7 days of a previous pertussis-containing vaccine), Tdap should not be administered, and the child should continue to receive Td for future tetanus and diphtheria protection 1.

  • For future tetanus protection, the child would need another tetanus-containing vaccine 10 years after receiving Tdap 1.

Clinical Pitfalls to Avoid

  1. Delaying Tdap administration: Some providers might incorrectly believe they need to wait several years before giving Tdap after Td. Current guidelines clearly state there is no minimum interval required 1.

  2. Using the wrong Tdap formulation: For a 10-year-old child, only Boostrix is licensed, not Adacel 1.

  3. Missing the opportunity for pertussis protection: Pertussis remains endemic in the United States and can cause significant morbidity. Ensuring timely pertussis vaccination is crucial for both individual and community protection 4.

  4. Confusing catch-up schedules: This situation (Td given instead of Tdap at age 10) is different from scenarios where children have incomplete primary vaccination series, which would require different catch-up approaches 1.

By promptly administering Tdap, you will ensure the child receives protection against pertussis while maintaining the established protection against tetanus and diphtheria, thus optimizing protection against all three diseases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Schedule for Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.